EGF and breast carcinoma: A significant increase in apoptotic cells in the triple-negative MDA-MB-231 cells could result from an alternative breast cancer progression pathway defined through over-expression of the epidermal growth factor (EGF)-induced nuclear factor κB (NF-κB) that can be activated for ER- negative breast cancer cells[48].